+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts



Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts



Journal of Biological Chemistry 263(10): 4586-4592



Transforming growth factors of the .beta.-class (TGFs-.beta.) stimulate extracellular matrix synthesis and have been implicated in embryogenesis, wound healing, and fibroproliferative responses to tissue injury. Because cells communicate with several extracellular matrix components via specific cell membrane receptors, we hypothesized that TGFs-.beta. may also regulate the expression of such receptors. We confirmed that TGF-.beta.1 increases the expression of fibronectin, an adhesive glycoprotein expression during embryogenesis and tissue remodeling. Based upon the 48-72 h period required for a maximal fibroproliferative response to dermal injection of TGF-.beta.1, we exposed human fetal lung fibroblasts (IMR-90) to TGF-.beta.1 for periods up to 48 h in vitro. We observed as much as 6-fold increases in fibronectin synthesis by 24 h as previously reported for fibroblastic cells (Ignotz, R. A., and Massague, J. (1986) J. Biol. Chem. 261, 4337-4345; Ignotz, R. A., Endo, T., and Massague, J. (1987) J. Biol. Chem. 262, 6443-6446; Raghow, R., Postlethwaithe, A. E., KeskiOja, J., Moses, H. L., and Kang, A. H. (1987) J. Clin. Invest. 79, 1285-1288), but up to 30-fold increases by 48 h. These increases are accompanied by similar increases in fibronectin mRNA levels which are prevented by actinomycin D treatment. Using a monospecific antibody raised to the human placental fibronectin receptor complex, we found that TGF-.beta.1 stimulated fibronectin receptor synthesis up to 20-40-fold and increase mRNA levels encoding both the .alpha. and .beta.-subunits up to 3-fold, compared to control IMR-90 in serum-free medium. Actinomycin D blocks TGF-.beta.1-mediated increases in receptor mRNA levels. The earliest detectable TGF-.beta.-mediated increases in fibronectin receptor complex protein synthesis and mRNA levels occur at 8 h, whereas the earliest increases in fibronectin protein synthesis and mRNA levels occur at 12 h. These results demonstrate that TGF-.beta.1 stimulates fibronectin receptor synthesis, extending the diverse stimulatory activities of this polypeptide to matrix receptors. In addition, because fibronectin matrix assembly may assembly may involve the fibronectin cell adhesive receptor complex, increased receptor expression may help drive deposition into matrix.

(PDF emailed within 1 workday: $29.90)

Accession: 006826872

Download citation: RISBibTeXText

PMID: 2965146


Related references

Transforming growth factor b stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. The Journal of Biological Chemistry 263: 86-92, 1988

Transforming growth factor-beta stimulates collagen and fibronectin synthesis by human corneal stromal fibroblasts in vitro. Current Eye Research 12(8): 703-709, 1993

Transforming growth factor-beta stimulates the expression of fibronectin by human keratinocytes. Journal of Investigative Dermatology 91(3): 207-212, 1988

Effects of fibronectin on transforming growth factor-beta synthesis by human lung fibroblasts. European Respiratory Journal 8(SUPPL 19): 547S, 1995

Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factor-beta 1. International Journal of Cancer 57(5): 742-746, 1994

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. Febs Letters 228(1): 42-44, 1988

Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican. Biochemical Journal 310: 73-81, 1995

Control of fibronectin receptor expression by fibronectin: antisense fibronectin RNA downmodulates the induction of fibronectin receptor by transforming growth factor beta1. Journal of Cellular Physiology 170(2): 138-144, 1997

Transforming growth factor beta causes a persistent increase in collagen and fibronectin synthesis and messenger rna levels in cultured human fibroblasts. Journal of Leukocyte Biology 42(5): 557, 1987

Fibronectin fibronectin receptor and transforming growth factor beta in murine granulomatous lung inflammation. Clinical Research 39(4): 846A, 1991

Regulation of human airway epithelial cell extracellular matrix invasion by human fetal lung fibroblasts in vitro a role for cellular fibronectin and transforming growth factor beta. American Review of Respiratory Disease 145(4 PART 2): A126, 1992

Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. Journal of Clinical Investigation 79(4): 1285-1288, 1987

Transforming growth factor beta tgf beta 1 but not platelet derived growth factor pdgf and asbestos increases expression of fibronectin and type 1 collagen mrna expression in rat lung fibroblasts. American Review of Respiratory Disease 145(4 PART 2): A841, 1992

Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. European Journal of Clinical Investigation 20(5): 487-493, 1990

Transforming growth factor beta 1 augments expression of type i procollagen and fibronectin in normal adult lung fibroblasts. American Review of Respiratory Disease 137(4 PART 2): 50, 1988